Home » Gain Weight Supplements » Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to …
Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to …
Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to …
WHITEHOUSE STATION, N.J.—-Merck today announced a non-exclusive license agreement with Laboratory Corporation of America® Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.
Related posts:
- Merck Wins Second Federal FOSAMAX® (alendronate sodium) Bellwether Trial
- (AFX UK Focus) 2010-05-14 19:48 UPDATE 1-US FDA: Glaxo, Merck vaccines OK despite pig virus
- FDA: Glaxo, Merck vaccines OK despite pig virus
Tags: Development, grants, Identify, LabCorp, License, Likely, Merck, patients, Potentially, Respond, Test —